which glp 1 agonists have cardiovascular benefit Reducing Risk of Major Adverse Events: Role of SGLT2 Inhibitors, GLP-1 The Benefits of GLP-1 Therapy:
Description
the AACE guidelines and the European Society of Cardiology (ESC)/EASD guidelines also recommend GLP1RAs for these patients irrespective of glycaemic control
Overall, DPP4i have a favourable therapeutic profile and are safe and effective in the majority of patients with type 2 diabetes mellitus
In rats, inhibition of gastric emptying occurs after peripheral or central administration of GLP-1 [795], and this effect is mediated via hindbrain GLP-1R signaling [806]
doi: 10.2337/dc20-1473
The increasing prevalence of such disorders necessitates government organizations to launch initiatives to reduce disease prevalence
Beyond physical health, obesity often carries substantial psychological and social burdens, such as depression, stigma, and reduced self-esteem [6]
